Health ❯ Healthcare ❯ Obesity

Weight Loss

Medications Pharmaceuticals GLP-1 Drugs Mounjaro GLP-1 Medications Weight Loss Injections Weight Loss Drugs GLP-1 Agonists Semaglutide Bariatric Surgery Prescription Drugs Medication Tirzepatide Clinical Trials Long-term Effects Cancer Risk Reduction Injectable Medications GLP-1 Treatments Interventions Medication for Weight Loss Weight Loss Medications Clinical Studies Surgical Methods Dietary Recommendations Weight-loss Injections Incretin Drugs Market Trends Zepbound Orforglipron Weight-Loss Surgery Metabolic Health Medication Accessibility Patient Outcomes Intervention Effectiveness Hormone Agonists Patient Care Obesity Drugs GLP-1 Receptor Agonists Behavioral Change Generic Medications GLP-1 Pill

Lancet Phase 3 Trial Shows Oral GLP-1 Orforglipron Aids Weight Loss and Diabetes Control

Lilly aims to seek approval with a potential 2026 rollout, positioning the once‑daily tablet as a more accessible alternative to injections.

Lilly to Launch Late-Stage Trials of Amylin Obesity Drug After 20% Weight Loss in Mid-Stage Study

Bariatric Surgery Outperforms GLP-1 Medicines Over 10 Years for Patients With Diabetes and Obesity

Meta-Analysis Finds Predictable Weight Rebound After Stopping Anti-Obesity Drugs

Bariatric Surgery Surpasses GLP-1 Drugs in Real-World Weight Loss